Reuters -- Drugmakers Bristol-Myers Squibb Co (BMY.N) and Pfizer (PFE.N) plan to seek in the first half of 2010 regulatory approval in Europe for apixaban, a drug meant to prevent and treat clots in blood vessels, the companies said on Friday.
Reuters -- Drugmakers Bristol-Myers Squibb Co (BMY.N) and Pfizer (PFE.N) plan to seek in the first half of 2010 regulatory approval in Europe for apixaban, a drug meant to prevent and treat clots in blood vessels, the companies said on Friday.
